Cilag AG
Records under this name other than the patents Cilag AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,772,411 | Process for the Preparation of (3R,3AS,6AR)-Hexahydrofuro [2,3-b] FURAN-3-YL (1S,2R)-3-[[(4-Aminophenyl) Sulfonyl] (ISOBUTYL) AMINO]-1-Benzyl-2-Hydroxypropylcarbamate Formerly held In force · High confidence | In force | High confidence | |
| US 7,923,558 | Method for Obtaining Pure Tetrahydrocannabinol Formerly held In force · High confidence | In force | High confidence | |
| US 8,227,609 | Process for Purifying Noroxymorphone Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 9,156,847 | Processes and Intermediates for Preparing a Medicament Formerly held In force · High confidence | In force | High confidence | |
| US 9,579,411 | Hydrogel Wound Dressings Exhibiting Reduced Fiber Losses in Use Formerly held In force · High confidence | In force | High confidence | |
| US 9,902,714 | Quinoxaline Derivatives Useful as FGFR Kinase Modulators Formerly held In force · High confidence | In force | High confidence | |
| US 10,421,747 | Quinoxaline Derivatives Useful as FGFR Kinase Modulators Formerly held In force · High confidence | In force | High confidence | |
| US 10,898,482 | Pharmaceutical Compositions Comprising N-(3,5-Dimethoxyphenyl)-N'-(1-Methylethyl)-N-[3-(1-Methyl-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-Diamine Formerly held In force · High confidence | In force | High confidence | |
| US 11,684,620 | Pharmaceutical Compositions Comprising N-(3,5-Dimethoxyphenyl)-N'-(1-Methylethyl)-N-[3-(1-Methyl-1H-PYRAZOL-4-YL)QUINOXALIN-6-YL]ETHANE-1,2-Diamine Formerly held In force · Medium confidence | In force | Medium confidence | |
| US D949,018 | Pharmaceutical Package Formerly held In force · High confidence | In force | High confidence |